Dimensional Fund Advisors Trims Johnson & Johnson Stake

Institutional investor sells over 500,000 shares of healthcare giant

Published on Mar. 4, 2026

Got story updates? Submit your updates here. ›

Dimensional Fund Advisors LP, a major institutional investor, reduced its holdings in Johnson & Johnson (NYSE: JNJ) by 2.9% during the third quarter of 2025. The firm sold 546,331 shares, leaving it with a remaining stake of 18,035,922 shares worth approximately $3.3 billion.

Why it matters

Johnson & Johnson is one of the world's largest and most influential healthcare companies, with a diverse portfolio spanning pharmaceuticals, medical devices, and consumer products. Changes in ownership by major institutional investors can signal shifts in market sentiment and influence the stock's performance.

The details

According to a regulatory filing, Dimensional Fund Advisors sold the 546,331 shares of Johnson & Johnson stock during the third quarter of 2025. This reduced the firm's total position in the company to around 18 million shares, or approximately 0.75% of Johnson & Johnson's outstanding stock.

  • Dimensional Fund Advisors sold the shares during the third quarter of 2025.

The players

Dimensional Fund Advisors LP

A global investment management firm that oversees over $600 billion in assets.

Johnson & Johnson

A multinational pharmaceutical and consumer goods company headquartered in New Brunswick, New Jersey.

Got photos? Submit your photos here. ›

The takeaway

The reduction in Dimensional Fund Advisors' Johnson & Johnson position, while relatively small, could signal a broader shift in investor sentiment towards the healthcare giant. However, the company remains a core holding for the firm, and its fundamentals continue to be viewed positively by many analysts.